Non Animal Testing Database

Vasoconstriction dynamics are altered in Alzheimer's disease

Frenchay Hospital, Bristol, United Kingdom
Alzheimer's disease is a neurodegenerative disorder that leads, among other things, to cognitive decline and, ultimately, death. It is the most prevalent dementia, but there are no effective tools to predict it or diagnose it at very early stages before the symptomatology is already detectable. Reduced cerebral blood flow has been proposed to occur before the formation of amyloid-beta plaques and cognitive abnormalities. Endothelin-1 is a vasoconstrictor present in the brain that is produced by neurons, through endothelin-converting enzyme 2, and in endothelial cells, by endothelin-converting enzyme 1. The first two have been shown to be elevated in post-mortem Alzheimer's patients' brains and their activity is modulated by amyloid-beta 42 in vitro. In this study, postmortem brains from Alzheimer's patients were studied to identify abnormalities of endothelin-1 and the enzymes related to it. The results show that leptomeningeal blood vessels from post-mortem brains had reduced levels of endothelin-converting enzyme 1, but its activity and endothelin-1 release were increased in Alzheimer's disease vessels. When primary cultures of human brain endothelial cells were stimulated with amyloid-beta 40 or 42, the researchers could see an increase in endothelin-1 release, contrary to when they added also the antioxidant superoxide dismutase. Overall, here it is shown that amyloid-beta could modulate the activity of factors related to vasoconstriction partially through the production of free radicals. This opens new possibilities to study the different pathways involved in this phenomenon to try to find new biomarkers and therapeutic targets.
Endothelin-converting enzyme-1 activity, endothelin-1 production, and free radical-dependent vasoconstriction in Alzheimer's disease
Jennifer C Palmer
Added on: 08-30-2021
Back to Top
English German

Warning: Internet Explorer

The IE from MS no longer understands current scripting languages, the latest main version (version 11) is from 2013 and has not been further developed since 2015.

Our recommendation: Use only the latest versions of modern browsers, for example Google Chrome, Mozilla Firefox or Microsofrt Edge, because only this guarantees you sufficient protection against infections and the correct display of websites!